TIKOMED AB
556622-8960ActiveDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
Yleiskatsaus
- 1–4
- Työntekijät
- 10–20milj SEK
- Liikevaihto
- 2002
- Perustettu
Avainpäättäjät
Erika Egrelius
Head of Quality Assurance
Merit Cudkowicz
Scientific Advisory Board Member
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
+17 lisää yhteystietoja Funnelfeedrissä
Kuvaus
TikoMed AB is a privately owned Swedish company established in 2002, focused on groundbreaking scientific innovation in drug development. The core of their work revolves around developing ILB®, a novel molecule demonstrating unique properties in stimulating the body’s natural repair mechanisms. This...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556622896001
Päättäjät
21 yhteystietoa FunnelfeedrissäErika Egrelius
Head of Quality Assurance
Merit Cudkowicz
Scientific Advisory Board Member
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
Jeremy Shefner
Scientific Advisory Board Member
Christian Treschow
Chairman
Estefanía Coral
Head of Communications
Juan Vergez
Board Member
Björn Pilström
Chief Executive Officer, Chief Medical Officer
Martin Bruce
Board Member
Anita Westin Tocaj
Head of Regulatory Affairs
Annika Kollén
Board Member
Tobhias Brandell
Board Member
Caroline Ingre
Scientific Advisory Board Member
Henrik Otendal
Chief Financial Officer, Human Resource Manager
Staffan Dahlgren
Head of Drug Safety
Adriano Chiò
Scientific Advisory Board Member
Christina Herder
Chair of the Board
Antonio Bermejo Gomez
Head of CMC
Johan Olsson
Head of Accounting
Anders Svensson
Board Member
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäLobSor Pharmaceuticals Aktiebolag
3 työntekijätDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Integrative Research Laboratories Sweden AB
20–49 työntekijätDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Grespo AB
0 työntekijätYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Lipigon Pharmaceuticals AB
5–9 työntekijätClinical-stage company developing novel drugs for lipid disorders.
AQILION AB
5–9 työntekijätDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Selaa lisää
Kysymyksiä yrityksestä TIKOMED AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo